-
Amicus Briefs On Biosimilar Patent Litigation – Courtesy (Pharma Patents)
POSTED BY COURTENAY C. BRINCKERHOFF ON 23 APRIL 2015POSTED IN BIOSIMILARSAmgen has appealed the district court decision denying its motion for a...
-
FDA Releases Draft Guidance on Biosimilars
POSTED BY COURTENAY C. BRINCKERHOFF ON 9 FEBRUARY 2012POSTED IN BIOSIMILARSOn February 9, 2012, the FDA issued long-awaited (draft) guidance documents on...
-
Judge Finds Biosimilar Patent Procedures Optional – Courtesy (Pharma Patent)
POSTED BY COURTENAY C. BRINCKERHOFF ON 23 MARCH 2015POSTED IN BIOSIMILARSJudge Seeborg of the U.S. District Court for the Northern District of...
-
Prepare for the Japanese Patent Opposition System Coming Soon – Courtesy (Global IP Matters)
The Japanese Patent Act was revised on May 14, 2014 to provide for post-grant oppositions within one year of the rule...
-
Stempeutics Gets Stem Cell Patent In China (Chinese Application Number: CN201080053627) For Its Novel Stem Cell Drug ‘Stempeucel’ – Courtesy(Biospace)
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced...
-
Comparing first level patent data with value-added patent information: A case study in the pharmaceutical field q
1-s2-0-s0172219008000823-mainDownload
-
Senator asks VA to yank patent on Gilead’s Sovaldi to crush its price – Courtesy (Fierce Pharma)
Gilead Sciences ($GILD) has been able to withstand scathing criticism at home over the prices of its hep C...
-
The Nasty Patent Games Drug Companies Play To Stop You From Getting Cheaper Drugs – Courtesy (TechDirt)
The astoundingly wonderful radio program/podcast Radiolab just recently had an episode called“Worth” — which included a few different stories trying...
